How Much Did Achira Raise?
Funding & Key Investors

Achira has successfully secured a major strategic investment, marking a pivotal moment in its operational trajectory. With a total capital accumulation of $33M, the firm is well-positioned to accelerate its research and development initiatives. This latest infusion of $33M underscores the market confidence in the company's proprietary approach to computational biology and its potential to disrupt traditional pharmaceutical research paradigms.

What is Achira?

Achira
Business ServicesResearch & DevelopmentEngineering Software

Founded in 2023 and headquartered in the United States, Achira operates at the intersection of biotechnology and advanced computational science. The company specializes in the development of sophisticated atomistic simulation models. By integrating geometric deep learning, physics-based modeling, quantum chemistry, and statistical mechanics, Achira provides a robust framework designed to streamline and enhance the drug discovery process. This multidisciplinary approach allows the firm to address complex molecular challenges that have historically hindered pharmaceutical innovation, positioning Achira as a critical player in the next generation of digital therapeutics and precision medicine.

How much funding has Achira raised?

Achira has raised a total of $33M across 1 funding round:

2025

Angel/Seed

$33M

Angel/Seed (2025): $33M with participation from NVentures and Amplify Partners

Key Investors in Achira

NVentures

NVentures is an upstream exploration firm that specializes in providing technical and commercial intelligence for the E&P and Energy industry, utilizing modern reporting and GIS tools.

Amplify Partners

Amplify Partners invests in early-stage companies pioneering novel applications in machine intelligence and computer science, with deep domain expertise in technical founding teams.

What's next for Achira?

Following this major enterprise-level funding, Achira is expected to scale its computational infrastructure and expand its technical team. The strategic allocation of capital will likely focus on refining its simulation engine to improve predictive accuracy in drug-target interactions. As the company transitions from its foundational phase to a more mature operational state, the focus will shift toward establishing high-value partnerships with global pharmaceutical entities. By leveraging its unique technological stack, Achira aims to reduce the time-to-market for novel therapeutics, effectively bridging the gap between theoretical quantum chemistry and practical clinical application.

See full Achira company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesField Service ManagementDocument Management
Business ServicesProject ManagementSoftware Testing
Business ServicesProject Management
Business ServicesProject Management

Frequently Asked Questions Regarding Achira Financial Insights

What are the most recent funding rounds that Achira has completed, and what were the funding rounds?
Achira has recently completed 1 funding rounds: Angel/Seed on Feb 24, 2025.
What is the total amount of funding Achira has raised to date?
Achira has raised a total of $33M in funding to date.
How many funding rounds has Achira completed?
Achira has completed 1 funding rounds.
How much funding did Achira raise in its most recent funding round?
Achira raised $33M in its most recent funding round.
Who are the lead investors in Achira's latest funding round?
The lead investor in Achira's latest funding round was NVentures. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Achira's history?
The largest funding round in Achira's history was $33M.
See more information about Achira